Monday, November 10, 2008
DrEddy Blog - Stories and opinion about health, illness and medicine
The patients receiving the drug, Crestor (rosuvastatin), did have high levels of C-reactive protein (CRP), a marker for the inflammation process which is implicated in hardening of the arteries. The study, sponsored by drug maker ...Read More
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment